HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Mark D Griffiths Selected Research
Mark D Griffiths Research Topics
Disease
16
COVID-19
01/2024 - 10/2020
7
Substance-Related Disorders (Drug Abuse)
01/2023 - 06/2018
5
Gambling (Pathological Gambling)
06/2023 - 09/2015
3
Infections
05/2023 - 10/2020
3
Sleep Initiation and Maintenance Disorders (Insomnia)
01/2023 - 01/2020
2
Stroke (Strokes)
01/2024 - 05/2023
2
Feeding and Eating Disorders (Eating Disorder)
06/2023 - 06/2021
2
Alcoholism (Alcohol Abuse)
01/2022 - 01/2019
2
Mental Disorders (Mental Disorder)
01/2020 - 01/2018
2
Substance Withdrawal Syndrome (Withdrawal Symptoms)
11/2017 - 06/2013
1
Tinnitus
01/2024
1
Hearing Loss (Hearing Impairment)
01/2024
1
Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2024
1
Dizziness (Lightheadedness)
01/2024
1
Hypertension (High Blood Pressure)
01/2024
1
Vertigo (Positional Vertigo)
01/2024
1
Migraine Disorders (Migraine)
01/2024
1
Genetic Predisposition to Disease (Genetic Predisposition)
11/2023
1
Fatigue
08/2023
1
Postpartum Depression (Post-Natal Depression)
08/2023
1
Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2023
1
Hypoglycemia (Reactive Hypoglycemia)
01/2023
1
Social Phobia
01/2023
1
Neoplasms (Cancer)
11/2022
1
Specific Phobia
01/2022
1
Overweight
12/2021
1
Breast Neoplasms (Breast Cancer)
12/2021
1
Human Influenza (Influenza)
10/2021
1
Bulimia (Binge Eating)
06/2021
1
Schizophrenia (Dementia Praecox)
11/2020
1
Heart Failure
01/2020
1
Atrophy
01/2020
1
Wounds and Injuries (Trauma)
01/2019
1
Warts (Wart)
01/2019
1
Death (Near-Death Experience)
01/2018
1
Confusion (Bewilderment)
06/2017
1
Fibromyalgia (Fibrositis)
02/2017
1
Compulsive Sexual Behavior Disorder
06/2016
1
Psychotic Disorders (Schizoaffective Disorder)
02/2014
Drug/Important Bio-Agent (IBA)
11
Immunoglobulin D (IgD)
IBA
01/2023 - 06/2017
6
COVID-19 Vaccines
IBA
01/2024 - 10/2021
5
Vaccines
IBA
01/2024 - 01/2021
3
4-amino-4'-hydroxylaminodiphenylsulfone (HADS)
IBA
01/2022 - 01/2020
3
Indicators and Reagents (Reagents)
IBA
01/2019 - 09/2015
2
Suspensions
IBA
02/2021 - 10/2020
1
Adenosine Triphosphate (ATP)
IBA
01/2024
1
Biological Factors
IBA
11/2023
1
Hypnotics and Sedatives (Sedatives)
IBA
06/2023
1
S-acetylthiorphan
IBA
01/2023
1
Psychotropic Drugs (Psychoactive Drugs)
IBA
01/2023
1
Insulin (Novolin)
FDA Link
01/2023
1
Influenza Vaccines (Influenza Vaccine)
FDA Link
11/2022
1
ORALIT (ORS)
IBA
11/2022
1
Glial Cell Line-Derived Neurotrophic Factor (GDNF)
IBA
04/2022
1
Illicit Drugs (Recreational Drugs)
IBA
01/2022
1
Complement System Proteins (Complement)
IBA
01/2022
1
Solutions
IBA
01/2022
1
N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)
IBA
01/2022
1
BES
IBA
06/2021
1
Prostaglandins A
IBA
06/2020
1
Estrogens (Estrogen)
FDA Link
01/2020
1
Adenosine Monophosphate (AMP)
IBA
01/2019
1
Nicotine
FDA Link
06/2018
Therapy/Procedure
4
Behavior Control
12/2021 - 06/2021
4
Meditation
01/2018 - 06/2013
3
Therapeutics
11/2022 - 02/2014
1
Acupressure (Shiatsu)
08/2023
1
Drug Therapy (Chemotherapy)
01/2022
1
Self Medication
11/2020